MARC Record from marc_nuls

LEADER: 03284cam a2200385 a 4500
001 9919299140001661
005 20170919123648.0
008 070926s2008 nyua b 001 0 eng c
010 $a 2007933065
020 $a9780387743486$q(alk. paper)
020 $a0387743480$q(alk. paper)
035 $a(OCoLC)173718705
035 $a(OCoLC)ocn173718705
040 $aNLM$beng$cPUL$dNLM$dUKM$dBAKER$dBTCTA$dYDXCP$dVRC$dMUQ$dDLC$dIG#$dMMU$dOCLCQ
042 $apcc
049 $aCNUM
050 4 $aQP801.C27$bC36 2008
082 04 $a615.7827$222
245 00 $aCannabinoids and the brain /$cAttila Köfalvi, editor ; editorial and chapters 1, 9, 14, 22 were proofed by Zsófia Gombár.
260 $aNew York :$bSpringer,$c©2008.
300 $axv, 583 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aMolecular biology, pharmacology, anatomy, and physiology of the endocannabinoid and related lipidergic signaling systems in the brain -- Historical introduction to the endocannabinoid and endovanilloid systems -- Biosynthesis of anandamide and 2-arachidonoylglycerol -- Removal of endocannabinoids by the body: mechanisms and therapeutic possibilities -- Other cannabimimetic lipid signaling molecules -- CB₁ cannabinoid receptors: molecular biology, second messenger coupling and polarized trafficking in neurons -- CB₂ cannabinoid receptors: molecular, signaling, and trafficking properties -- CB₁ and CB₂ receptor pharmacology -- Functional molecular biology of the TRPV₁ ion channel -- Alternative interacting sites and novel receptors for cannabinoid ligands -- Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord: circuitries and neurochemistry -- Endocannabinoids at the synapse: retrograde signaling and presynaptic plasticity in the brain -- Endocannabinoid functions in neurogenesis, neuronal migration, and specification -- Endocannabinoid system in clinical neuroscience and experimental neuropsychiatry -- Cannabinoids in the management of nausea and vomiting -- Endocannabinoids in energy homeostasis and metabolic disorders -- Cannabinoids and neuroprotection -- Neuroinflammation and the glial endocannabinoid system -- Targeting cannabinoid receptors in brain tumors -- Cannabinoids for the control of multiple sclerosis -- Endocannabinoids in Alzheimer's disease -- Endocannabinoid system as a therapeutic target in epilepsy -- Endocannabinoid system in the physiology and pathology of the basal ganglia -- Endocannabinoid system is a major player in schizophrenia -- Cannabinoid controversy: cannabinoid agonists and antagonists as potential novel therapies for mood disorders -- Role of cannabinoid receptors in anxiety disorders.
650 0 $aCannabinoids$xPhysiological effect.
650 0 $aCannabinoids$xReceptors.
650 0 $aCellular signal transduction.
650 0 $aNeuropharmacology.
700 1 $aKöfalvi, Attila.
947 $fCOLS-SCI$hCIRCSTACKS$p$136.74$q1
949 $aQP801.C27 C36 2008
994 $a92$bCNU
999 $aQP 801 .C27 C36 2008$wLC$c1$i31786102599773$lCIRCSTACKS$mNULS$rY$sY$tBOOK$u12/9/2009